We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+8.15%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+367.78%
AUM
$287B
AUM Growth
+$27.6B
Cap. Flow
+$6.59B
Cap. Flow %
2.29%
Top 10 Hldgs %
12.98%
Holding
8,864
New
808
Increased
4,306
Reduced
2,684
Closed
688

Sector Composition

Rank Sector Weight
1 Technology 9.82%
2 Financials 7.38%
3 Healthcare 6.65%
4 Consumer Discretionary 5.46%
5 Industrials 5.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PACD
5776
DELISTED
Pacific Drilling S.A. Common Shares
PACD
$151K ﹤0.01%
36,932
+14,075
+62% +$44K
FQAL icon
5777
Fidelity Quality Factor ETF
FQAL
$1.46B
$150K ﹤0.01%
4,000
+1,030
+35% +$37.3K
GIS icon
5778
CALL
General Mills
GIS
$19.7B
$150K ﹤0.01%
2,800
-4,400
-61% -$232K
REGN icon
5779
CALL
Regeneron Pharmaceuticals
REGN
$80.8B
$150K ﹤0.01%
400
+350
+700% +$118K
VIR icon
5780
Vir Biotechnology
VIR
$1.49B
$150K ﹤0.01%
+11,957
New +$160K
HFRO
5781
Highland Opportunities and Income Fund
HFRO
$407M
$149K ﹤0.01%
11,953
+9,074
+315% +$109K
NET icon
5782
Cloudflare
NET
$107B
$149K ﹤0.01%
8,723
+5,367
+160% +$91.4K
NVAX icon
5783
Novavax
NVAX
$1.31B
$149K ﹤0.01%
37,496
+19,828
+112% +$86K
PTGX icon
5784
Protagonist Therapeutics
PTGX
$9.44B
$149K ﹤0.01%
21,159
+4,540
+27% +$45.1K
BCEL
5785
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
$149K ﹤0.01%
9,653
+3,692
+62% +$44.6K
FGBI icon
5786
First Guaranty Bancshares
FGBI
$159M
$148K ﹤0.01%
7,478
+2,011
+37% +$35.9K
MUX icon
5787
McEwen Inc
MUX
$1.18B
$148K ﹤0.01%
11,672
+2,472
+27% +$34.9K
STRO icon
5788
Sutro Biopharma
STRO
$421M
$148K ﹤0.01%
1,346
+477
+55% +$49.2K
FEO
5789
DELISTED
First Trust/abrdn Emerging Opportunity Fund
FEO
$148K ﹤0.01%
10,402
+641
+7% +$8.82K
GALT icon
5790
Galectin Therapeutics
GALT
$348M
$147K ﹤0.01%
51,319
+17,891
+54% +$62.2K
IDT icon
5791
IDT Corp
IDT
$1.62B
$147K ﹤0.01%
20,353
+6,792
+50% +$48.9K
IRMD icon
5792
iRadimed
IRMD
$1.18B
$147K ﹤0.01%
6,284
+1,427
+29% +$33.3K
LEGH icon
5793
Legacy Housing
LEGH
$694M
$147K ﹤0.01%
8,859
+2,790
+46% +$43.7K
PXJ icon
5794
Invesco Oil & Gas Services ETF
PXJ
$61.3M
$147K ﹤0.01%
5,249
-4,440
-46% -$108K
SGMO
5795
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$147K ﹤0.01%
17,475
-158,242
-90% -$1.46M
AXJL
5796
DELISTED
WisdomTree Asia-Pacific ex-Japan Fund
AXJL
$147K ﹤0.01%
2,126
-219
-9% -$14.6K
NANR icon
5797
State Street SPDR S&P North American Natural Resources ETF
NANR
$785M
$146K ﹤0.01%
4,334
-541
-11% -$17.1K
ROOF
5798
DELISTED
NYLI CBRE NextGen Real Estate ETF
ROOF
$146K ﹤0.01%
5,659
-2,494
-31% -$64.6K
KSM
5799
DELISTED
DWS Strategic Municipal Income Trust
KSM
$146K ﹤0.01%
12,352
+3,142
+34% +$37.8K
MGI
5800
DELISTED
MoneyGram International, Inc. New
MGI
$146K ﹤0.01%
69,305
-1,638
-2% -$5.26K

Similar funds

UBS Group's Q4 2019 Portfolio in Review

As of Q4 2019, UBS Group held 8,864 positions worth $287B, up 11% from $260B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

UBS Group's Q4 2019 filing shows 808 new, 4,306 increased, 2,684 reduced and 688 closed positions. Its largest new stake was Bristol-Myers Squibb Company Contingent Value Rights: 5,302,748 shares worth $16M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.3B.

By sector, the portfolio is most concentrated in Technology at 9.8% of assets, up from 9.5% a quarter earlier, followed by Financials and Healthcare.

  • UBS Group's largest Q4 2019 buy was Bristol-Myers Squibb Company Contingent Value Rights: 5,302,748 shares worth $16M.
  • UBS Group added most to UBS Group in Q4 2019, an estimated $1.48B increase.
  • UBS Group's biggest Q4 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.3B.
  • UBS Group fully exited Altaba Inc in Q4 2019, selling an estimated $759M.
  • UBS Group's ten largest holdings make up 13% of its $287B portfolio in Q4 2019.
  • UBS Group opened 808 new positions and closed 688 in Q4 2019.
  • UBS Group's portfolio value rose 11% quarter-over-quarter to $287B.

Based on UBS Group's 13F filing for Q4 2019, filed 14 Feb 2020.